Financière de Tubize SA (LON:0D53)

Market Cap	8.51B +84.2%
Revenue (ttm)	n/a
Net Income	81.33M +3.5%
EPS	1.83 +3.5%
Shares Out	n/a
PE Ratio	104.69
Forward PE	n/a
Dividend	0.65 (0.29%)
Ex-Dividend Date	May 7, 2026

Volume	n/a
Open	220.80
Previous Close	223.00
Day's Range	220.80 - 223.20
52-Week Range	125.00 - 250.50
Beta	0.37
Analysts	n/a
Price Target	n/a
Earnings Date	Mar 21, 2026

About Financière de Tubize

Financière de Tubize SA holds a stake in UCB, a biopharmaceutical company in Belgium. It focuses on the discovery and development of treatments for patients suffering from diseases affecting immune or central nervous system. The company was founded in 1928 and is based in Brussels, Belgium.

• Industry: Investors, not elsewhere classified
• Founded: 1928
• Employees: 3
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0D53

Financial Performance

Financial numbers in EUR